Clinical trial Recruiting at 1 site Interventional Ages 18 to 59

Baduanjin exercise for improving health in sedentary adults

Official title: A Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Mechanisms of Baduanjin on Improving Health Outcomes in Sedentary Young and Middle-Aged Adults

Run by China-Japan Friendship Hospital · NCT07482995 · Data updated 2026-11-12

A 12-week Baduanjin exercise program is being tested to see if it can improve fitness, body composition, strength, balance, flexibility, and daily sitting time in sedentary adults aged 18–59.

Quick facts

Study typeInterventional
Ages18 Years to 59 Years
SexAll
Enrollment208 (estimated)
SponsorChina-Japan Friendship Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedSeptember 30, 2026
Main results expectedSeptember 30, 2027
Study endsOctober 10, 2027
Registry record updatedNovember 5, 2026
Trial IDNCT07482995 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18–59 who are sedentary (≥8 hours of daily sitting) and do not meet WHO activity guidelines, in generally good health, and able to participate in supervised exercise.

Probably not a fit

Participants who cannot commit to the 12-week program or who do not respond to or tolerate Baduanjin may not receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares a supervised plus home-based 12-week Baduanjin exercise program to a health education control in sedentary young and middle-aged adults. Participants will undergo baseline, mid-point, and end-of-study assessments including cardiopulmonary fitness tests, body measurements, strength and balance tests, and questionnaires. The study aims to determine whether Baduanjin can meaningfully improve cardiorespiratory fitness, body composition, muscle strength, balance, flexibility, and daily sedentary time compared with health education. Enrollment is limited to adults 18–59 who sit many hours daily, do not meet WHO physical activity guidelines, and are in generally good health.

Why it matters

Potential benefit: If successful, participants in the Baduanjin group may experience better fitness and daily activity levels, potentially reducing health risks associated with a sedentary lifestyle.

How similar studies have gone: Previous studies in similar populations have shown benefits from structured exercise programs, but this exact Baduanjin approach in sedentary adults is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 to 59 years
* Sedentary and physically inactive, defined as: (a) self-reported sitting time ≥ 8 hours per day, AND (b) not meeting the World Health Organization (WHO) recommended level of physical activity ( engaging in \< 150 minutes of moderate-to-vigorous intensity physical activity per week, assessed by the International Physical Activity Questionnaire \[IPAQ\])
* In good general health as self-reported, and free from any known diseases
* Willing and able to provide written informed consent

Exclusion Criteria:

* Contraindications to cardiopulmonary exercise testing
* Currently participating in, or planning to participate within the next 3 months, in any other structured exercise or behavioral intervention program
* Pregnancy, lactation, or planning to become pregnant during the study period
* Inability to understand or comply with the study procedures

Where it's running

  • China-Japan Friendship Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.